Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.40 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4883632 | 0.98 | KDM4E (0.52) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL36932 | 0.97 | KDM4E (0.55) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL16271531 | 0.90 | KDM4E (0.47) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL11947048 | 0.90 | KDM4E (0.43) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL20886601 | 0.89 | L3MBTL1 (0.51) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL17739642 | 0.89 | KDM4E (0.46) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL17752700 | 0.88 | KDM4E (0.53) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL11947029 | 0.88 | KDM4E (0.48) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL17759776 | 0.88 | L3MBTL1 (0.50) | KDM4EL3MBTL1ATMLMNATDP1 | |
| SCHEMBL12690642 | 0.88 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10764974-B2 | Light-emitting device using organometallic complex having a pyrazine skeleton | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-10764974-B2 | Light-emitting device using organometallic complex having a pyrazine skeleton | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-09-01 | — | — | US | disclosed |
| US-20190053351-A1 | Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
| US-20190053351-A1 | Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | UDC IRELAND LIMITED (IE) | 2019-01-01 | — | — | US | disclosed |
| US-10129947-B2 | Light-emitting device using organometallic complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-11-13 | — | — | US | disclosed |
| US-10079350-B2 | Organometallic complex, composition and light emitting element including the organometallic complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-09-18 | — | — | US | disclosed |
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | UDC IRELAND LTD (IE) | 2017-02-16 | — | — | US | disclosed |
| EP-1973386-A2 | Light-emitting device and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-09-24 | — | — | EP | disclosed |
| US-20080149923-A1 | Light-emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-06-26 | — | — | US | disclosed |
| US-20080149923-A1 | Light-emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-06-26 | — | — | US | disclosed |
| US-20080149923-A1 | Light-emitting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-06-26 | — | — | US | disclosed |
| WO-2008065975-A1 | LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-06-05 | — | — | WO | disclosed |
| US-20080079353-A1 | Quinoxaline Derivative, And Light-Emitting Device, Electronic Device Using The Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-03 | — | — | US | disclosed |
| US-20080079353-A1 | Quinoxaline Derivative, And Light-Emitting Device, Electronic Device Using The Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-03 | — | — | US | disclosed |
| US-20080079353-A1 | Quinoxaline Derivative, And Light-Emitting Device, Electronic Device Using The Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-03 | — | — | US | disclosed |
| EP-1905768-A1 | Quinoxaline derivative, and light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1905768-A1 | Quinoxaline derivative, and light-emitting device, electronic device using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10167303-B2 | Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex | NDUFS5, DDT, NDUFV2 | KDM4E 1275/4885L3MBTL1 1863/4885ATM 3489/4885 |
| US-10079350-B2 | Organometallic complex, composition and light emitting element including the organometallic complex | PPOX, RPL15, LAGE3 | KDM4E 2700/4885L3MBTL1 2125/4885ATM 1583/4885 |
| US-20170044194-A1 | Metal Complexes with Dibenzo[f,h]quinoxalines | NDUFS2, OCIAD2, NDUFS3 | KDM4E 3445/4885L3MBTL1 2458/4885ATM 4417/4885 |
| US-20080079353-A1 | Quinoxaline Derivative, And Light-Emitting Device, Electronic Device Using The Quinoxaline Derivative | HSF1, NQO2, NQO1 | KDM4E 2188/4885L3MBTL1 1186/4885ATM 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.